Financial News

Novogen's TRXE-009 shows potential

Novogen Ltd. (Nasdaq: NVGN) announced that TRXE-009 demonstrated potential to kill brain cancer stem cells sending the stock price soaring $1.09 to $3.61.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback